Evidence map›Paper›PMID 36597534›Full record

ArticlemedRxiv : the preprint server for health sciences2022

A machine learning-based phenotype for long COVID in children: an EHR-based study from the RECOVER program.

Vitaly Lorman, Hanieh Razzaghi, Xing Song, Keith Morse, Levon Utidjian, Andrea J Allen, Suchitra Rao, Colin Rogerson, Tellen D Bennett, Hiroki Morizono and 8 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 1 country.

Vitaly LormanApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Hanieh RazzaghiApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Xing SongDepartment of Health Management and Informatics, University of Missouri School of Medicine, Columbia, MO, United States.
Keith MorseDivision of Pediatric Hospital Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, United States.
Levon UtidjianApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Andrea J AllenApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Suchitra RaoDepartment of Pediatrics, University of Colorado School of Medicine and Children's Hospital of Colorado, Aurora, CO, United States.
Colin RogersonDivision of Critical Care, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States.
Tellen D BennettDepartments of Biomedical Informatics and Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, United States.
Hiroki MorizonoCenter for Genetic Medicine Research, Children's National Hospital, Washington DC, United States.
Daniel EckrichBiomedical Research Informatics Center, Nemours Children's Health, Wilmington, DE, United States.
Ravi JhaveriDivision of Infectious Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.
Yungui HuangIT Research and Innovation, The Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
Daksha RanadeResearch Informatics Department, Seattle Children's Hospital, Seattle, WA, United States.
Nathan PajorDivision of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Grace M LeeDivision of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, United States.
Christopher B ForrestApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
L Charles BaileyApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Children's Hospital of Philadelphia · USChildren's Hospital Colorado · USChildren's National · USCincinnati Children's Hospital Medical Center · USIndiana University School of MedicineLurie Children's Hospital · USNationwide Children's Hospital · USNemours Children's Health System · USSeattle Children's Hospital · USStanford Medicine · USStanford University · USUniversity of Missouri Health System · US

Funding

OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository CoreOT2HL161847 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GROSS, RACHEL SHARON, HORWITZ, LEORA · 2021 to 2025
$651.0M
NHLBI NIH HHS OT2 HL161847
6 · The paper itself

Abstract

Background: As clinical understanding of pediatric Post-Acute Sequelae of SARS CoV-2 (PASC) develops, and hence the clinical definition evolves, it is desirable to have a method to reliably identify patients who are likely to have post-acute sequelae of SARS CoV-2 (PASC) in health systems data. Methods and Findings: In this study, we developed and validated a machine learning algorithm to classify which patients have PASC (distinguishing between Multisystem Inflammatory Syndrome in Children (MIS-C) and non-MIS-C variants) from a cohort of patients with positive SARS-CoV-2 test results in pediatric health systems within the PEDSnet EHR network. Patient features included in the model were selected from conditions, procedures, performance of diagnostic testing, and medications using a tree-based scan statistic approach. We used an XGboost model, with hyperparameters selected through cross-validated grid search, and model performance was assessed using 5-fold cross-validation. Model predictions and feature importance were evaluated using Shapley Additive exPlanation (SHAP) values. Conclusions: The model provides a tool for identifying patients with PASC and an approach to characterizing PASC using diagnosis, medication, laboratory, and procedure features in health systems data. Using appropriate threshold settings, the model can be used to identify PASC patients in health systems data at higher precision for inclusion in studies or at higher recall in screening for clinical trials, especially in settings where PASC diagnosis codes are used less frequently or less reliably. Analysis of how specific features contribute to the classification process may assist in gaining a better understanding of features that are associated with PASC diagnoses. Funding Source: This research was funded by the National Institutes of Health (NIH) Agreement OT2HL161847-01 as part of the Researching COVID to Enhance Recovery (RECOVER) program of research. Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the RECOVER Program, the NIH or other funders.

Identifiers

PMID36597534
PMCPMC9810222
OpenAlexW4313238388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.